Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,567Revenue $M9,429Net Margin (%)9.0Altman Z-Score2.1
Enterprise Value $M26,396EPS $1.7Operating Margin %15.5Piotroski F-Score7
P/E(ttm)23.8Beneish M-Score-1.9Pre-tax Margin (%)9.7Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %12.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %8.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow32.7y-y EBITDA Growth Rate %3.6ROA % (ttm)4.1Higher Current Ratio y-yY
Dividend Yield %--PEG2.9ROE % (ttm)10.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M492ROIC % (ttm)8.8Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 41.83-13%Add 81.62%853,749
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 41.83-13%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 41.83-13%Reduce -60.67%26,450
MYLJohn Keeley 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 41.83-13%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 41.83-25%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 41.83-25%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 41.83-25%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 41.83-25%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 41.83-41%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 41.83-41%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.49)
$ 41.83-41%Sold Out0
MYLJohn Keeley 2015-06-30 Buy 0.06%$57.94 - $76.06
($70.49)
$ 41.83-41%New holding37,050
MYLJoel Greenblatt 2015-06-30 Sold Out -0.01%$57.94 - $76.06
($70.49)
$ 41.83-41%Sold Out0
MYLMario Gabelli 2015-06-30 Add0.01%$57.94 - $76.06
($70.49)
$ 41.83-41%Add 232.50%33,250
MYLJoel Greenblatt 2015-03-31 Reduce-0.3%$52.74 - $64.96
($57.01)
$ 41.83-27%Reduce -97.62%16,021
MYLVanguard Health Care Fund 2015-03-31 Add0.11%$52.74 - $64.96
($57.01)
$ 41.83-27%Add 5.68%15,891,898
MYLFirst Eagle Investment 2015-03-31 Reduce-0.04%$52.74 - $64.96
($57.01)
$ 41.83-27%Reduce -30.38%586,016
MYLJohn Paulson 2014-12-31 Add0.72%$46.5 - $58.62
($53.92)
$ 41.83-22%Add 19.64%14,948,400
MYLJoel Greenblatt 2014-12-31 Buy 0.31%$46.5 - $58.62
($53.92)
$ 41.83-22%New holding673,287
MYLVanguard Health Care Fund 2014-12-31 Reduce-0.05%$46.5 - $58.62
($53.83)
$ 41.83-22%Reduce -2.64%15,037,080
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHEEHAN JOHN DEVP and CFO 2015-12-17Sell34,579$55.03-23.99view
HIGGINS MELINA EDirector 2015-06-15Sell8,351$73.08-42.76view
Cindrich Robert JDirector 2015-02-03Sell40,645$53.15-21.3view
CAMERON WENDYDirector 2015-02-03Sell106,551$53.15-21.3view
COURY ROBERT JExecutive Chairman 2015-02-03Sell947,119$52.55-20.4view
Malik RajivPresident 2015-02-03Sell285,394$53.15-21.3view
MAROON JOSEPH C MDDirector 2015-02-03Sell136,551$53.15-21.3view
BRESCH HEATHER MCEO 2015-02-03Sell411,996$53.15-21.3view
DIMICK NEIL FDirector 2015-02-03Sell19,781$53.15-21.3view
Mauro AnthonyPresident, North America 2015-02-03Sell13,255$53.15-21.3view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    David Einhorn Rebounds – Somewhat Feb 09 2016 
    Keeley Funds Comments on Mylan N.V. Feb 03 2016 
    KEELEY All Cap Value Fund Commentary - 4th Quarter 2015 Feb 03 2016 
    David Einhorn Comments on Mylan Jan 19 2016 
    Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    Health Care Investor Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    John Paulson Keeps Gold, Buys Drug Manufacturers Nov 17 2015 
    Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
    Keeley Funds Comments on Mylan NV Nov 03 2015 
    Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Nov 02 2015 

    More From Other Websites
    Mylan NV Earnings Analysis: Q4, 2015 By the Numbers Feb 12 2016
    Mylan has paid a high price for Sweden’s Meda, but deal has strategic benefits Feb 12 2016
    Here’s Why Mylan’s Stock Plunged Feb 11 2016
    M&A Misanthropes? Investors Become More Wary of Deals. Feb 11 2016
    [$$] Mylan defends $9.9bn Meda deal after shares fall Feb 11 2016
    Mylan shareholders recoil after $7.2B deal for Meda Feb 11 2016
    Thursday links: a little frustrated Feb 11 2016
    Mylan: The Market Really, Really, Really Doesn't Like the Meda Deal Feb 11 2016
    How Sturdy Is the M&A Market? Feb 11 2016
    This drugmaker spent 2 years trying to buy another company — and now that it has, its shares are... Feb 11 2016
    Tesla's stock accelerates; Mylan sinks on $7.2B deal; Zynga gets crushed Feb 11 2016
    Mylan N.V. -- Moody's affirms Mylan's Baa3; outlook stable Feb 11 2016
    Mylan Q4 Earnings and Revenues Lag, Set To Acquire Meda Feb 11 2016
    Mylan (MYL) Stock Plummets on $7.2 Billion Meda Acquisition, Earnings Miss Feb 11 2016
    Mylan CEO on $7.2B deal for Meda Feb 11 2016
    Early movers: PEP, NLSN, AVP, TWTR, TSLA & more Feb 11 2016
    Mylan CEO: Building for the long term Feb 11 2016
    Edited Transcript of MYL earnings conference call or presentation 10-Feb-16 9:30pm GMT Feb 11 2016
    Mylan Slumps on $7.2 Billion `Wealth Destroying' Meda Deal Feb 11 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK